FAM190A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.587000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.093000E-01
Normal-vs-Stage2
9.466400E-01
Normal-vs-Stage3
4.465000E-01
Normal-vs-Stage4
4.143200E-01
Stage1-vs-Stage2
2.919400E-01
Stage1-vs-Stage3
7.516000E-01
Stage1-vs-Stage4
6.412300E-02
Stage2-vs-Stage3
2.741000E-01
Stage2-vs-Stage4
1.411640E-01
Stage3-vs-Stage4
8.049500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.649600E-01
Normal-vs-AfricanAmerican
7.472400E-01
Normal-vs-Asian
8.545000E-01
Caucasian-vs-AfricanAmerican
5.337600E-01
Caucasian-vs-Asian
7.464200E-01
AfricanAmerican-vs-Asian
4.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.788400E-01
Normal-vs-Female
8.635200E-01
Male-vs-Female
4.747200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.239000E-01
Normal-vs-Age(41-60Yrs)
7.012000E-01
Normal-vs-Age(61-80Yrs)
8.200800E-01
Normal-vs-Age(81-100Yrs)
3.543800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.780000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.174400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.636600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.281900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.839200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.150000E-01
Normal-vs-Daily Drinker
9.519200E-01
Normal-vs-Weekly Drinker
7.253800E-01
Normal-vs-Occasional Drinker
8.695200E-01
Normal-vs-Social Drinker
9.614800E-01
Non Drinker-vs-Daily Drinker
7.253400E-01
Non Drinker-vs-Weekly Drinker
5.137000E-01
Non Drinker-vs-Occasional Drinker
5.584000E-01
Non Drinker-vs-Social Drinker
8.930200E-01
Daily Drinker-vs-Weekly Drinker
4.520600E-01
Daily Drinker-vs-Occasional Drinker
8.677000E-01
Daily Drinker-vs-Social Drinker
8.283800E-01
Weekly Drinker-vs-Occasional Drinker
3.429200E-01
Weekly Drinker-vs-Social Drinker
5.065200E-01
Occasional Drinker-vs-Social Drinker
6.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.04930000536186E-08
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
3.11469738889514E-11
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.018400E-01
Grade 1-vs-Grade 3
2.788400E-02
Grade 1-vs-Grade 4
6.04930000536186E-08
Grade 2-vs-Grade 3
1.862380E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
3.11469738889514E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.280600E-01
Normal-vs-NonDiabetic
8.847800E-01
Diabetic-vs-NonDiabetic
8.705400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.837400E-01
Normal-vs-NoPancreatitis
8.848200E-01
Pancreatitis-vs-NoPancreatitis
2.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.515400E-01
Normal-vs-N1
9.881000E-01
N0-vs-N1
8.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.167400E-01
Normal-vs-TP53-NonMutant
9.978000E-01
TP53-Mutant-vs-TP53-NonMutant
2.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
